XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Treasury Stock
Total
Beginning Balance at Sep. 30, 2019 $ 857 $ 1,921,954 $ 3,511 $ (586,412) $ (200,956) $ 1,138,954
Beginning Balance (in shares) at Sep. 30, 2019 85,759,700          
Increase (Decrease) in Stockholders' Equity            
Shares issued under restricted stock and purchase plans, net $ 16 4,579       4,595
Shares issued under restricted stock and purchase plans, net (in shares) 1,534,010          
Stock-based compensation   16,317       16,317
Common stock dividends declared       (29,513)   (29,513)
Net income       64,853   64,853
Foreign currency translation adjustments     18,877     18,877
Changes in unrealized gains on marketable securities, net of tax     7     7
Actuarial loss, net of tax effects     (476)     (476)
Ending Balance at Sep. 30, 2020 $ 873 1,942,850 21,919 (551,072) (200,956) 1,213,614
Ending Balance (in shares) at Sep. 30, 2020 87,293,710          
Increase (Decrease) in Stockholders' Equity            
Shares issued under restricted stock and purchase plans, net $ 5 5,806       5,811
Shares issued under restricted stock and purchase plans, net (in shares) 515,212          
Stock-based compensation   27,456       27,456
Common stock dividends declared       (29,726)   (29,726)
Net income       110,747   110,747
Foreign currency translation adjustments     (2,922)     (2,922)
Actuarial loss, net of tax effects     354     354
Ending Balance at Sep. 30, 2021 $ 878 1,976,112 19,351 (470,051) (200,956) $ 1,325,334
Ending Balance (in shares) at Sep. 30, 2021 87,808,922         74,347,053
Increase (Decrease) in Stockholders' Equity            
Shares issued under restricted stock and purchase plans, net $ 7 5,239       $ 5,246
Shares issued under restricted stock and purchase plans, net (in shares) 673,203          
Stock-based compensation   10,666       10,666
Common stock dividends declared       (7,494)   (7,494)
Net income       2,132,859   2,132,859
Unrealized gain on derivative asset, net of tax effects     93,020     93,020
Foreign currency translation reclassification adjustments included in income from discontinued operation (Note 2)     (16,567)     (16,567)
Foreign currency translation adjustments     (169,266)     (169,266)
Changes in unrealized gains on marketable securities, net of tax     (10,908)     (10,908)
Actuarial loss, net of tax effects     454     454
Other       42   42
Ending Balance at Sep. 30, 2022 $ 885 $ 1,992,017 $ (83,916) $ 1,655,356 $ (200,956) $ 3,363,386
Ending Balance (in shares) at Sep. 30, 2022 88,482,125         75,020,256